BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 13677943)

  • 1. [Genetic aspect of essential hypertension].
    Umemura S
    Rinsho Byori; 2003 Aug; 51(8):813-7. PubMed ID: 13677943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors associated with volume-sensitive hypertension.
    Williams GH
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):41-4. PubMed ID: 15134799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of human arterial hypertension.
    Naber CK; Siffert W
    Minerva Med; 2004 Oct; 95(5):347-56. PubMed ID: 15467511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
    Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
    Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meta-analysis on the association of AGT M235T polymorphism and essential hypertension in Chinese population].
    Chen P; Jiang YF; Cheng K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):711-4. PubMed ID: 14521795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
    Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
    Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
    Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
    J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Gupta M; Javed S; Pasha MQ
    J Hypertens; 2008 Jun; 26(6):1094-101. PubMed ID: 18475146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
    Ramu P; Rajan S; Shewade DG; Swaminathan RP; Dutta TK; Balachander J; Adithan C
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):576-82. PubMed ID: 19673943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: The Shigaraki Study.
    Tamaki S; Nakamura Y; Tabara Y; Okamura T; Kita Y; Kadowaki T; Tsujita Y; Horie M; Miki T; Ueshima H
    Hypertens Res; 2005 Aug; 28(8):645-50. PubMed ID: 16392768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both angiotensinogen M235T and alpha-adducin G460W polymorphisms are associated with hypertension in the Japanese population.
    Nakamura Y; Tabara Y; Miki T; Tamaki S; Kita Y; Okamura T; Ueshima H
    J Hum Hypertens; 2007 Mar; 21(3):253-5. PubMed ID: 17215849
    [No Abstract]   [Full Text] [Related]  

  • 14. Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis.
    Wu SJ; Chiang FT; Chen WJ; Liu PH; Hsu KL; Hwang JJ; Lai LP; Lin JL; Tseng CD; Tseng YZ
    Physiol Genomics; 2004 Apr; 17(2):79-86. PubMed ID: 14970360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.
    Jiang X; Sheng HH; Lin G; Li J; Lu XZ; Cheng YL; Huang J; Xiao HS; Zhan YY
    Chin Med J (Engl); 2007 May; 120(9):782-6. PubMed ID: 17531119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular diseases and molecular variants of the renin-angiotensin system components in Slovak population.
    Jurkovicova D; Sedlakova B; Riecansky I; Goncalvesova E; Penesova A; Kvetnansky R; Krizanova O
    Gen Physiol Biophys; 2007 Mar; 26(1):27-32. PubMed ID: 17579251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population.
    Niu W; Qi Y; Cen W; Cui C; Zhuoma C; Cai D; Zhou W; Qiu C
    Hypertens Res; 2007 Nov; 30(11):1129-37. PubMed ID: 18250562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of hypertension. Therapeutic implications.
    O'Byrne S; Caulfield M
    Drugs; 1998 Aug; 56(2):203-14. PubMed ID: 9711445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients.
    van den Born BJ; van Montfrans GA; Uitterlinden AG; Zwinderman AH; Koopmans RP
    J Hypertens; 2007 Nov; 25(11):2227-33. PubMed ID: 17921816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.